WeVote

Bill

Bill

SB 62

PHARMACY BENEFIT MANAGER FEES

2025 Regular Session Introduced by Liz Stefanics and 1 co-sponsor

SB 62 would regulate pharmacy benefit manager fees to reduce prescription drug costs for New Mexico consumers, though it stalled in committee and faced industry pushback.

action postponed indefinitely
0
WeVote Research Nonpartisan
Bill Summary · SB 62

Legislative bill overview

SB 62 would regulate fees charged by Pharmacy Benefit Managers (PBMs)—intermediaries that manage prescription drug benefits for insurers and employers. The bill appears designed to increase transparency and/or cap administrative fees that PBMs charge to pharmacies and patients, though specific fee structures aren't detailed in the available information.

Why is this important

PBMs control which drugs are covered and at what cost, significantly affecting prescription drug affordability for New Mexico residents. Rising PBM fees are passed along to consumers through higher copays and insurance premiums, making this a direct healthcare affordability issue affecting thousands of state residents.

Potential points of contention

  • Industry opposition: PBMs argue fee regulations reduce their ability to negotiate drug prices and manage costs; they may claim the bill would ultimately increase prescription drug prices
  • Implementation complexity: Defining which fees are "excessive" versus reasonable business costs requires detailed regulatory frameworks that could be difficult to enforce
  • Limited leverage: New Mexico alone may struggle to regulate multi-state PBM operations without federal coordination, potentially reducing the bill's practical effectiveness

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.